1. Home
  2. BW vs MNKD Comparison

BW vs MNKD Comparison

Compare BW & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Babcock & Wilcox Enterprises Inc.

BW

Babcock & Wilcox Enterprises Inc.

N/A

Current Price

$3.59

Market Cap

1.2B

Sector

Industrials

ML Signal

N/A

Logo MannKind Corporation

MNKD

MannKind Corporation

N/A

Current Price

$3.90

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BW
MNKD
Founded
1867
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2015
2004

Fundamental Metrics

Financial Performance
Metric
BW
MNKD
Price
$3.59
$3.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
9
Target Price
★ $16.25
$8.33
AVG Volume (30 Days)
★ 5.1M
3.0M
Earning Date
11-09-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 41.46
N/A
EPS
★ N/A
N/A
Revenue
★ $1,062,388,000.00
$348,966,000.00
Revenue This Year
$86.64
$26.63
Revenue Next Year
$22.38
$14.81
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 22.23
52 Week Low
$3.07
$2.23
52 Week High
$22.03
$6.51

Technical Indicators

Market Signals
Indicator
BW
MNKD
Relative Strength Index (RSI) 35.91 53.12
Support Level $3.07 $3.77
Resistance Level $4.68 $4.24
Average True Range (ATR) 0.51 0.21
MACD 0.05 -0.01
Stochastic Oscillator 21.57 38.44

Price Performance

Historical Comparison
BW
MNKD

About BW Babcock & Wilcox Enterprises Inc.

Babcock & Wilcox Enterprises Inc is an energy technologies provider offering energy and emissions control solutions to a broad range of industrial, electrical utility, municipal, and other customers. It offers technologies that utilize coal, natural gas, hydrogen, waste, and biomass to produce energy, environmental solutions, and carbon capture systems. The company's product portfolio comprises steam generation systems, environmental solutions, combustion and fuel systems, and related equipment and services. Additionally, it offers specialized technologies (BrightLoop) in industrial energy production, including hydrogen and syngas. Geographically, the company generates maximum revenue from the United States, and the rest from Canada, the UK, Indonesia, the Philippines, and other markets.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company dedicated to transforming chronic disease care through patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, it develops and commercializes treatments that address unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.

Share on Social Networks: